Skip to main content
Normal View

Wednesday, 26 Feb 2014

Written Answers Nos. 259-267

Cancer Screening Programmes

Questions (259)

Arthur Spring

Question:

259. Deputy Arthur Spring asked the Minister for Health if multidisciplinary teams are utilised to make cancer diagnoses; the way they are configured; the radiologists involved; the pathologists involved; if there is any provision for oversight in the system; if there is any provision to allow access to digital X-rays at the time of acquisition; if there is provision to provide women with tissue samples to facilitate independent confirmation of the diagnosis such as happens with Garda acquired blood samples; and if he will make a statement on the matter. [9930/14]

View answer

Written answers

BreastCheck, the national breast cancer screening programme, operates standards and quality assurance systems that are in line with international guidelines to ensure that the most effective service is provided to women. A specialist BreastCheck multidisciplinary team provides the screening service. Quality assurance standards in operation include the double reading of all mammograms by two specially trained radiologists. Pathologists take part in external Quality Assurance and independent slide review. The entire BreastCheck programme is subject to external review by EUREF, the European Reference Organisation for Quality Assured Breast Screening and Diagnostic Services, with the next review scheduled for Autumn 2014.

Women who have an abnormality on screening will be recalled to an assessment clinic for triple assessment. Such clinics are attended by a radiologist, a breast surgeon, a breast care nurse and appropriate radiography staff. Further imaging, including supplementary mammographic views and ultrasound, clinical examination and either needle biopsy or fine needle aspiration as required is carried out.

A multidisciplinary meeting takes place on a regular basis at each unit to review individual cases. Radiation oncologists and medical oncologists involved in the programme are normally involved in the medical review of all cases of diagnosed breast cancer. Correlation of clinical, radiological and pathological results is performed and the outcome is documented. Further clinical management as required is arranged immediately.

The BreastCheck Women's Charter encourages women to share in decision-making regarding treatment. The Charter highlights the woman’s right to refuse treatment for whatever reason, to obtain a second opinion or to choose alternative treatment. If she so wishes, the woman is encouraged to include a partner, friend or relative in any discussions. Copies of their medical results can be obtained by all women.

Cancer Screening Programmes

Questions (260)

Arthur Spring

Question:

260. Deputy Arthur Spring asked the Minister for Health if his attention has been drawn to the 1,298 women who have developed breast cancer subsequent to a clear screening National Cancer Register and that the interval cancer rate at 38% of anticipated cancer rate with an additional 525 women who also developed cancer subsequent to clear screening places Ireland firmly at the top of breast cancer interval cancer rates; and if he will make a statement on the matter. [9931/14]

View answer

Written answers

Interval cancers, involving breast cancers diagnosed in the interval between scheduled screenings, where women have been given a normal screening result at their most recent screening, inevitably arise in any screening programme.

Cancer can occur at any time, including during periods between mammograms. Also, not all breast cancers can be found by means of mammogram. Some non-invasive cancers will not be found by screening and interval cancers can occur in such cases.

However, the overall benefits of breast screening are clear. Breast screening helps to diagnose breast cancer at an early stage when it is easier to treat, thus exposing the women involved to less extensive surgical treatment and giving them better chances of good recoveries and improved quality of life.

Cancer Screening Programmes

Questions (261, 262, 263)

Arthur Spring

Question:

261. Deputy Arthur Spring asked the Minister for Health if the clinical trial published in 2009 demonstrated a statistically significant increase in breast cancer on each occasion the digital mammogram machine was used; if it is reasonable to use this machine at all; and if he will make a statement on the matter. [9932/14]

View answer

Arthur Spring

Question:

262. Deputy Arthur Spring asked the Minister for Health if the publication of the Swiss Medical Board might influence his decision; and if he will make a statement on the matter. [9933/14]

View answer

Arthur Spring

Question:

263. Deputy Arthur Spring asked the Minister for Health if a phase one clinical trial has taken place here on digital mammography; if so, if the women were consulted on the risks involved in a clinical trial; where the trial was initiated; if the outcomes demonstrate an increase in breast cancer in the women screened with the digital machine; the corrective action taken at that point; and if he will make a statement on the matter. [9934/14]

View answer

Written answers

I propose to take Questions Nos. 261 to 263, inclusive, together.

Prior to its introduction on a national scale, digital mammography was introduced on a pilot basis in Ireland. Based on the success of the pilot, BreastCheck transferred to digital mammography. Digital mammography gives enhanced image quality with improved visualisation of dense breast tissue. It allows images to be acquired more quickly and enables the manipulation of images to obtain better detail. Digital mammography also involves a significant reduction in the radiation dose associated with screening examinations.

A research study sponsored by the US National Cancer Institute, Digital Mammographic Imaging Screening Trial (DMIST), provides evidence to support the efficacy and safety of digital mammography. BreastCheck continues to review all relevant research as it is published. The extensive independent breast screening review for the United Kingdom (Marmot Review) published in 2012 demonstrated that breast screening leads to a reduction in mortality.

A clinical trial on digital mammography has not been carried out in Ireland.

Medical Card Eligibility

Questions (264)

Charlie McConalogue

Question:

264. Deputy Charlie McConalogue asked the Minister for Health the reason the application of a person who would be eligible for a medical card under EU regulations as a cross-border worker must be assessed under a household means test in order to clarify if the rest of the family qualifies for a medical card, even though the family do not wish to be considered for a medical card; and if he will make a statement on the matter. [9941/14]

View answer

Written answers

Regulation (EC) 883/04 and Implementing Regulation 987/09 provide for the coordination of social security systems, including health care, within the EU/EEA and Switzerland, with the aim of ensuring the free movement of persons. This objective of the Regulation is to ensure that persons exercising their right to move and to stay freely within the EU/EEA and Switzerland do not suffer disadvantage.

Medical Cards may be issued to EU\EEA citizens under EU Regulation 883/04 if the person is in receipt of a contributory social insurance payment from one, or more, of the Member States, provided they are not receiving a contributory social insurance payment from the Irish State. EU\EEA citizens who are in receipt of a qualifying payment from another member State should make an application for a Medical Card directly to the HSE. Such applicants are not means tested. The application should be accompanied, as evidence that they are receiving a qualifying payment, by the relevant EU "S" form issued by the Member State making their payment. The position regarding the UK is that, under a reciprocal agreement, the EU "S" form is not required, however, proof of receipt of a qualifying payment from the UK authorities should be provided with the application to the HSE.

Autism Support Services

Questions (265)

Michael McCarthy

Question:

265. Deputy Michael McCarthy asked the Minister for Health his plans to develop an autism specific database for children and adults; and if he will make a statement on the matter. [9943/14]

View answer

Written answers

The Value for Money (VFM) and Policy Review of Disability Services recommended reviewing the resources engaged in data collection, the overall information requirements necessary to support monitoring and reviewing disability services provided and the contribution which is being made from existing databases. In that context, my Department, in conjunction with the HSE, has committed to review current information systems and to examine the development of robust information systems to meet the core objective in relation to planning, monitoring and evaluating health and personal social services. The VFM Review and the Expert Policy Group Report did not make any recommendations in relation to a condition-specific database. Neither my Department nor the HSE have plans to develop such a database at present.

Maternity Services

Questions (266, 267)

Finian McGrath

Question:

266. Deputy Finian McGrath asked the Minister for Health the terms of reference for the development of the national strategy; the body responsible for drawing up the strategy; and if he will make a statement on the matter. [9962/14]

View answer

Finian McGrath

Question:

267. Deputy Finian McGrath asked the Minister for Health the position regarding the draft document commissioned by the West/North West Hospitals Group which recommends that maternity services in the region would continue only at Galway University Hospital and Letterkenny General Hospital; if this will have any influence on the national maternity strategy; and if he will make a statement on the matter. [9963/14]

View answer

Written answers

I propose to take Questions Nos. 266 and 267 together.

My Department is currently developing a new National Strategy for Maternity Services which will determine the optimal configuration of maternity services to ensure that women in Ireland have access to safe, high quality maternity care in a setting most appropriate to their needs. As part of the development of the Strategy, maternity services in all parts of the country will be reviewed and evaluated. This is in line with one of the recommendations of the HIQA report into the death of Savita Halappanavar. I intend to publish the Strategy this year.

Maternity services in the West/North West Hospital Group are the subject of a high level strategic review. A draft report, which presents options for the delivery of maternity and gynaecology services in to the future, is currently under consideration by the Hospital Group Board. The review will, when finalised, inform the National Strategy. The Deputy may wish to note that the draft report makes no recommendations in relation to the closure of any of the five maternity units within the West/North West Hospital Group.

Top
Share